Japan Tissue Engineering Co., Ltd. (7774) Other
Market cap
¥24.3B
P/E ratio
-45x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 0.4 | 5.7 | 2.6 | 1.7 | 0.9 | -0.7 | -2 | -1.4 | 2.8 | 1.4 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 126 | 137 | 157 | 170 | 179 | 174 | 174 | 184 | 186 | 200 | 207 | 215 | 211 | 204 |